[Federal Register Volume 80, Number 182 (Monday, September 21, 2015)]
[Notices]
[Pages 56997-56999]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-23568]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-15-0009; Docket No. CDC-2015-0083]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
revision of the information collection entitled ``National Disease
Surveillance Program--I--Case Reports.''
DATES: Written comments must be received on or before November 20,
2015.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2015-
0083 by any of the following methods:
Federal eRulemaking Portal: Regulation.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact the Information Collection Review Office,
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
[[Page 56998]]
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services
to provide information. Burden means the total time, effort, or
financial resources expended by persons to generate, maintain, retain,
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; to develop, acquire,
install and utilize technology and systems for the purpose of
collecting, validating and verifying information, processing and
maintaining information, and disclosing and providing information; to
train personnel and to be able to respond to a collection of
information, to search data sources, to complete and review the
collection of information; and to transmit or otherwise disclose the
information.
Proposed Project
National Disease Surveillance Program I--Case Reports--(OMB Control
Number 0920-0009, Expiration, 4/30/2016)--Revision--National Center for
Emerging and Zoonotic Infectious Disease (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Surveillance of the incidence and distribution of disease has been
an important function of the US Public Health Service (PHS) since an
1878 Act of Congress authorized the PHS to collect morbidity reports.
After the Malaria Control in War Areas Program had fulfilled its
original 1942 objective of reducing malaria transmission, its basic
tenets were carried forward and broadened by the formation of the
Communicable Disease Center (CDC) in 1946. CDC was conceived of as a
well-equipped, broadly staffed agency used to translate facts about
analysis of morbidity and mortality statistics on communicable diseases
and through field investigations.
The surveillance emphasis has shifted as certain diseases have
declined in incidence, national emergencies have prompted involvement
in new areas, and other diseases have taken on new aspects.
Surveillance for the following diseases was approved three years ago:
Creutzfeldt-Jakob Disease (CJD), Cyclosporiasis cayetanensis, Q Fever,
Dengue, Reye Syndrome, Hantavirus pulmonary syndrome (HPS), Tick-borne
Rickettsial Disease, Kawasaki syndrome, Trichinosis, Legionellosis,
Tularemia, Lyme Disease (LD), Typhoid Fever, Malaria, Viral Hepatitis,
and Plague. Due to change requests and surveillance systems moving to
0920-0728 (National Notifiable Diseases Surveillance System (NNDSS))
during the last three years, the following diseases/conditions are now
included in this program: Creutzfeldt-Jakob Disease (CJD), Reye
Syndrome, Kawasaki syndrome, and Acute Flaccid Myelitis. CDC needs to
continue this surveillance package for another 3 years to maintain
continuity in these surveillance systems. The data throughout the years
are used to monitor the occurrence of non-notifiable conditions and to
plan and conduct prevention and control programs at the state,
territorial, local and national levels.
CDC currently collects data for certain diseases in summary form
under OMB No. 0920-0004, (National Disease Surveillance Program II--
Disease Summaries). These disease summaries are for important, yet
different types of infections from those covered in this disease case
reports request. Maintaining separate OMB numbers for these two types
of data collections assists CDC in managing the two surveillance
activities.
CDC works with state health departments to propose, coordinate, and
evaluate nationwide surveillance systems. State epidemiologists are
responsible for the collection, interpretation, and transmission of
medical and epidemiological information to CDC.
The original purpose for reporting communicable diseases was to
determine the prevalence of diseases dangerous to public health.
However, collecting data also provided the basis for planning and
evaluating effective programs for prevention and control of infectious
diseases. Current information on disease incidence is needed to study
present and emerging disease problems. CDC coordination of nationwide
reporting maintains uniformity so that comparisons can be made from
state to state and year to year.
In addition to development of prevention and control programs,
surveillance data serves as statistical material for those engaged in
research or medical practice, aid to health education officials and
students, and data for manufacturers of pharmaceutical products. Annual
surveillance data are published in the MMWR Surveillance Summary. The
total burden requested is 190 hours, a decrease in 11,257 hours since
the last submission. This is due to the other diseases moving to the
Notifiable Diseases Surveillance System (0920-0728). There is no cost
to respondents other than their time.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hrs.) (in hrs.)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Epidemiologist................................. CJD.................................... 20 2 20/60 13
Epidemiologist................................. Kawasaki Syndrome...................... 55 8 15/60 110
Epidemiologist................................. Reye Syndrome.......................... 50 1 20/60 17
Epidemiologist................................. Acute Flaccid Myelitis................. 100 1 30/60 50
Total...................................... ....................................... .............. .............. .............. 190
--------------------------------------------------------------------------------------------------------------------------------------------------------
[[Page 56999]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-23568 Filed 9-18-15; 8:45 am]
BILLING CODE 4163-18-P